Physician profile
Sonali Nanda
NPI 1871121848
$5,603.50
in general payments reported to CMS, 2019-2025
17 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $467 · 2023: $3,506 · 2024: $1,481 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,445 · Travel and Lodging: $1,691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,445.04 |
| Travel and Lodging | $1,691.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,401.47 | 2022-2024 | |
| Lilly USA, LLC | $668.16 | 2023-2024 | Olumiant, Taltz, Zepbound |
| Janssen Biotech, INC. | $286.10 | 2023-2025 | Tremfya |
| Dermavant Sciences, INC. | $277.79 | 2023-2024 | Vtama |
| Boehringer Ingelheim Pharmaceuticals, INC. | $274.62 | 2023-2024 | Spevigo |
| Genzyme Corporation | $247.53 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $224.89 | 2023 | Sotyktu |
| Ucb, INC. | $216.86 | 2023-2024 | Bimzelx |
| Kyowa Kirin, INC. | $199.72 | 2022-2023 | Poteligeo |
| Mallinckrodt Hospital Products INC. | $144.35 | 2024 | Uvadex |
| Arcutis Biotherapeutics, INC. | $134.64 | 2024 | Zoryve |
| Janssen Scientific Affairs, LLC | $118.32 | 2022 | |
| Organogenesis INC. | $114.20 | 2023 | Puraply |
| Incyte Corporation | $100.33 | 2023 | Opzelura |
| Kerecis Limited | $100.30 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $77.26 | 2022 | |
| Convatec INC. | $16.96 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonali Nanda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.